Company: CERO
Filing Date: 2025-08-22
Form Type: 424B3
Source: 0001213900-25-080011
Chunk: 49

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 424B3
Chunk 49
---
 closing of the Fourth PIPE Financing is at the option of the investors upon notice to the Company and subject to satisfaction of customary closing conditions.

Purchase of Common Stock by Keystone Capital Partners under the Equity Line of Credit (“ELOC”)

On February 14, 2024, in
conjunction with, and as a condition to the closing of the Series A PIPE Financing, the Company entered into a common stock purchase
agreement (the “February 2024 Keystone Purchase Agreement”) with Keystone Capital Partners, L.P. (“Keystone”),
pursuant to which we may sell and issue, and Keystone is obligated to purchase, up to 12,500 shares subject to the Company obtaining
all necessary stockholder approvals to issue the shares to Keystone. The price of the shares purchased by Keystone under the ELOC is
90% of various volume-weighted average price (“VWAP”) and closing price-based formulae, and requires a waiver, should the
selling price be below $2,000.00 per share. As consideration for Keystone’s commitment to purchase shares of Common Stock pursuant
to the Old Keystone Purchase Agreement, we issued an aggregate of 932 shares of Common Stock to Keystone.

During the three months ended June 30, 2024, the Company sold 3,930 shares for gross proceeds of approximately $2.5 million under the Keystone ELOC. The Company sought and received a waiver to sell the shares below $2,000.00 per share. The Company also issued 125 and 185 shares of common stock to Keystone as consideration for the ELOC in the three-month period ended June 30, 2024 and the period from February 14, 2024 to June 30, 2024, respectively. The $2.5 million gross proceeds included $194,971 of Stock Subscription Receivable for end of period purchases for which the Company had not yet received cash payment by June 30, 2024, and $933,345 of issuance costs, including issuances of Common Stock as consideration for the ELOC.

<div align='center'>21</div>

On November 8, 2024, the
Company consummated a purchase agreement with Keystone (the “November 2024 Keystone Purchase Agreement”) pursuant to which
we may sell and issue, and Keystone is obligated to purchase, up to $20.6 million of shares of Common Stock, constituting the remaining
unsold balance under the original Keystone Purchase Agreement, subject to certain market conditions